Skip to content

Vote · Roll call

Amendment 164

Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest

Vote
Amendment 164
Result
450 for · 205 against · 8 abstained Adopted · roll call
Date
20 January 2026, 12:46
More facts (6)
Position
vote 8 of 43 on the decision
Requested by
roll call: Patriots
Official label
A10-0272/2025 – Tomislav Sokol – Amendments by the committee responsible – separate vote – Am 164
Vote id
183251
More

Result

The vote as recorded by name.

Result: 450 for, 205 against, 8 abstained (roll call).

Adopted · 68 % of the votes cast were for.

Groups

Members' votes, each counted in the group they belonged to on the day. No vote: in office that day, no position recorded. Majority line: the most common position. Clear line: a position with at least two thirds of the group's votes (at least 10 members voting), otherwise Divided. Cohesion: Agreement Index, 0 = evenly split, 1 = all voted the same (method).
GroupForAgainstAbst.No voteMajority lineClear lineCohesionBar
The LeftFor 3Against 35Abst. 0No vote 8 of 46Majority line AgainstClear line Against Cohesion 0.88
GreensFor 50Against 0Abst. 0No vote 3 of 53Majority line ForClear line For Cohesion 1.00
S&DFor 76Against 48Abst. 0No vote 12 of 136Majority line ForClear line Divided Cohesion 0.42
RenewFor 62Against 5Abst. 0No vote 8 of 75Majority line ForClear line For Cohesion 0.89
EPPFor 177Against 4Abst. 1No vote 6 of 188Majority line ForClear line For Cohesion 0.96
ECRFor 62Against 10Abst. 1No vote 6 of 79Majority line ForClear line For Cohesion 0.77
PatriotsFor 7Against 72Abst. 0No vote 6 of 85Majority line AgainstClear line Against Cohesion 0.87
ESNFor 0Against 24Abst. 0No vote 3 of 27Majority line AgainstClear line Against Cohesion 1.00
No groupFor 13Against 7Abst. 6No vote 4 of 30Majority line —Clear line No line Cohesion —

Members who changed group are counted in the group of the day: Branko GRIMS changed group, Elena YONCHEVA changed group, Elisabetta GUALMINI changed group, Ewa ZAJĄCZKOWSKA-HERNIK changed group, Jessika VAN LEEUWEN changed group, Laurent CASTILLO changed group, Lukas SIEPER changed group, Nikola BARTŮŠEK changed group, Nikolas FARANTOURIS changed group, Pina PICIERNO changed group, Roberto VANNACCI changed group, Sander SMIT changed group, Taner KABILOV changed group.

Countries × groups

How each country’s members of each group voted.

Greens members by country who voted for, against or abstained (group at the date of the vote).
CountryForAgainstAbst.Bar
Austria200
Belgium200
Czechia100
Germany1400
Denmark300
Spain400
Finland200
France400
Croatia100
Italy400
Lithuania100
Luxembourg100
Latvia100
Netherlands600
Romania100
Sweden200
Slovenia100

Members

Each member’s recorded position, in the group they sat in that day. Filter by country, group, position or name.

Show all 663 members

No vote recorded, 56

Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.

Show the 56 members

Name · group that day · country

Similar votes

Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.

Result: for–against–abstained. For: share of the votes cast. Requested by: the groups that asked for a roll call.
DateVoteKindResultForRequested byr · shared
13 Nov 2025Amendment 45 to Article 2 — part 1 Certain corporate sustainability reporting and due diligence requirementsAmendment496 for, 138 against, 13 abstained Adopted For 77 %Requested by The Leftr · shared0.68 605 voters
22 Oct 2025Separate vote on recital D Institutional consequences of the EU enlargement negotiationsSeparate vote464 for, 136 against, 42 abstained Adopted For 72 %Requested by Membersr · shared0.67 598 voters
7 May 2025Separate vote on paragraph 88 The European Water Resilience StrategySeparate vote460 for, 165 against, 18 abstained Adopted For 72 %Requested by Membersr · shared0.67 596 voters
Show 7 more
Result: for–against–abstained. For: share of the votes cast. Requested by: the groups that asked for a roll call.
DateVoteKindResultForRequested byr · shared
17 Jun 2026Separate vote on paragraph 42 2025 Commission report on TürkiyeSeparate vote470 for, 125 against, 60 abstained Adopted For 72 %Requested by The Leftr · shared0.67 605 voters
12 Mar 202511-12 November Parliament’s calendar of part-sessions – 2026Other294 for, 77 against, 7 abstained Adopted For 78 %r · shared0.66 350 voters
22 Jan 2026Separate vote on paragraph 98 European technological sovereignty and digital infrastructureSeparate vote459 for, 140 against, 34 abstained Adopted For 73 %Requested by Membersr · shared0.65 615 voters
20 Jan 2026Final vote — text as a whole The 28th Regime: a new legal framework for innovative companiesFinal492 for, 144 against, 28 abstained Adopted For 74 %r · shared0.65 657 voters
9 Jul 2025Paragraph 15 — part 2 The human cost of Russia’s war against Ukraine and the urgent need to end Russian aggression: the situation of illegally detained civilians and prisoners of war, and the continued bombing of civiliansSplit vote489 for, 151 against, 32 abstained Adopted For 73 %Requested by Patriotsr · shared0.65 617 voters
27 Nov 2025Paragraph 252 — part 6 Implementation of the EU-UK Trade and Cooperation AgreementSplit vote424 for, 152 against, 14 abstained Adopted For 72 %Requested by The Leftr · shared0.65 555 voters
8 Jul 2025Final vote — text as a whole Security of energy supply in the EUFinal459 for, 170 against, 30 abstained Adopted For 70 %r · shared0.65 607 voters

How similarity is measured

Compare with another vote

Groups’ lines side by side, and the members who switched between the two votes.

Connections

This vote’s decision, the other votes on it, and related votes.

Show 11 connections: The decision · Other votes on this decision

The decision

Other votes on this decision

See all: Other votes on this decision

Sources & citation

Where the facts on this page come from, and how to cite it.

Retrieved
25 September 2026

Cite as

European Parliament (2026). “Amendment 164 — Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest”. Vote, 20 January 2026. votingId 183251, reference 2025/0102(COD). EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2026-01-20/183251 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 20 January 2026 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-RCV_EN.html; Results of votes, sitting of 20 January 2026 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2026-01-20, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2026-01-20/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).
BibTeX
@misc{epw-vote-2026-01-20-183251,
  author = {{European Parliament}},
  title = {{Amendment 164 — Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest}},
  year = {2026},
  date = {2026-01-20},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2026-01-20/183251}},
  url = {https://news.eu-parl.st-solutions.dev/votes/2026-01-20/183251},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Vote. votingId 183251, reference 2025/0102(COD). Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2026-01-20 (CC BY 4.0)}
}